PON1 and Alzheimer disease: We found that apoC-I levels were significantly decreased in bvFTD compared to both AD and controls (Figures 6A,B), PON1 levels were significantly increased in AD compared to both bvFTD and controls (Figure 6C), and SERPINA1 levels were unaltered in both bvFTD and AD compared to controls (Figure 6D).